Literature DB >> 10810639

Modulation of the immune response through 4-1BB.

G Sica1, L Chen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10810639     DOI: 10.1007/0-306-46817-4_30

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  14 in total

1.  Novel CD137 Gene Polymorphisms and Susceptibility to Ischemic Stroke in the Northern Chinese Han Population.

Authors:  Shuang Zhang; Zongmin Li; Ruyou Zhang; Xiaoying Li; Hewei Zheng; Qi Ma; Hui Zhang; Wenying Hou; Feng Zhang; Yingnan Wu; Litao Sun; Jiawei Tian
Journal:  Neuromolecular Med       Date:  2017-07-28       Impact factor: 3.843

2.  Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors.

Authors:  Ryan A Wilcox; Dallas B Flies; Gefeng Zhu; Aaron J Johnson; Koji Tamada; Andrei I Chapoval; Scott E Strome; Larry R Pease; Lieping Chen
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 3.  Immunotherapy and immunoescape in colorectal cancer.

Authors:  Guillermo Mazzolini; Oihana Murillo; Catalina Atorrasagasti; Juan Dubrot; Iñigo Tirapu; Miguel Rizzo; Ainhoa Arina; Carlos Alfaro; Arantza Azpilicueta; Carmen Berasain; José L Perez-Gracia; Alvaro Gonzalez; Ignacio Melero
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

4.  4-1BB functions as a survival factor in dendritic cells.

Authors:  Beom K Choi; Young H Kim; Patrick M Kwon; Sang C Lee; Sang W Kang; Moon S Kim; Myoung J Lee; Byoung S Kwon
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

5.  Inhibition of proliferation and induction of apoptosis in multiple myeloma cell lines by CD137 ligand signaling.

Authors:  Charles Gullo; Liang Kai Koh; Wan Lu Pang; Kian Tong Ho; Shi Hao Tan; Herbert Schwarz
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

6.  A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity.

Authors:  Yangbing Zhao; Qiong J Wang; Shicheng Yang; James N Kochenderfer; Zhili Zheng; Xiaosong Zhong; Michel Sadelain; Zelig Eshhar; Steven A Rosenberg; Richard A Morgan
Journal:  J Immunol       Date:  2009-11-01       Impact factor: 5.422

7.  Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice.

Authors:  James O McNamara; Despina Kolonias; Fernando Pastor; Robert S Mittler; Lieping Chen; Paloma H Giangrande; Bruce Sullenger; Eli Gilboa
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

8.  Expression of 4-1BB and 4-1BBL in thymocytes during thymus regeneration.

Authors:  Young-Mi Kim; Hye Kyung Kim; Hyo Jin Kim; Hee-Woo Lee; Seong-A Ju; Beom K Choi; Byoung S Kwon; Bong-Seon Kim; Jae-Bong Kim; Young-Tak Lim; Sik Yoon
Journal:  Exp Mol Med       Date:  2009-12-31       Impact factor: 8.718

Review 9.  Nucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical Sensing.

Authors:  Ti-Hsuan Ku; Tiantian Zhang; Hua Luo; Tony M Yen; Ping-Wei Chen; Yuanyuan Han; Yu-Hwa Lo
Journal:  Sensors (Basel)       Date:  2015-07-06       Impact factor: 3.576

Review 10.  Costimulation-based immunotherapy for head and neck cancer.

Authors:  Scott E Strome; Lieping Chen
Journal:  Curr Treat Options Oncol       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.